BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30030157)

  • 1. The potential of transdermal nitric oxide treatment for diabetic peripheral neuropathy and diabetic foot ulcers.
    Walton DM; Minton SD; Cook AD
    Diabetes Metab Syndr; 2019; 13(5):3053-3056. PubMed ID: 30030157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic painful neuropathy: current and future treatment options.
    Chong MS; Hester J
    Drugs; 2007; 67(4):569-85. PubMed ID: 17352515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy.
    Jang HN; Oh TJ
    Diabetes Metab J; 2023 Nov; 47(6):743-756. PubMed ID: 37670573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Clinical Trial of Nitrosense patch for the treatment of patients with painful diabetic neuropathy.
    Agrawal RP; Jain S; Goyal S; Singhal S; Lindgren L; Sthengel E
    J Assoc Physicians India; 2014 May; 62(5):385-90. PubMed ID: 25438482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy.
    Tesfaye S; Selvarajah D
    Diabetes Metab Res Rev; 2012 Feb; 28 Suppl 1():8-14. PubMed ID: 22271716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management.
    Tesfaye S; Vileikyte L; Rayman G; Sindrup SH; Perkins BA; Baconja M; Vinik AI; Boulton AJ;
    Diabetes Metab Res Rev; 2011 Oct; 27(7):629-38. PubMed ID: 21695762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral neuropathy in persons with diabetes.
    Handevidt F
    Clin Excell Nurse Pract; 2001; 5(1):17-20. PubMed ID: 11154389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic peripheral neuropathy and gait: does footwear modify this association?
    Grewal GS; Bharara M; Menzies R; Talal TK; Armstrong D; Najafi B
    J Diabetes Sci Technol; 2013 Sep; 7(5):1138-46. PubMed ID: 24124939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burning through the pain: treatments for diabetic neuropathy.
    Javed S; Alam U; Malik RA
    Diabetes Obes Metab; 2015 Dec; 17(12):1115-25. PubMed ID: 26179288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.
    Stepanović-Petrović R; Micov A; Tomić M; Pecikoza U
    Psychopharmacology (Berl); 2017 Jun; 234(11):1781-1794. PubMed ID: 28332005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives.
    Gore M; Brandenburg NA; Hoffman DL; Tai KS; Stacey B
    J Pain; 2006 Dec; 7(12):892-900. PubMed ID: 17157775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The health care costs of diabetic peripheral neuropathy in the US.
    Gordois A; Scuffham P; Shearer A; Oglesby A; Tobian JA
    Diabetes Care; 2003 Jun; 26(6):1790-5. PubMed ID: 12766111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy.
    Iqbal Z; Azmi S; Yadav R; Ferdousi M; Kumar M; Cuthbertson DJ; Lim J; Malik RA; Alam U
    Clin Ther; 2018 Jun; 40(6):828-849. PubMed ID: 29709457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic peripheral neuropathic pain: recognition and management.
    Cole BE
    Pain Med; 2007 Sep; 8 Suppl 2():S27-32. PubMed ID: 17714113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues.
    Argoff CE; Cole BE; Fishbain DA; Irving GA
    Mayo Clin Proc; 2006 Apr; 81(4 Suppl):S3-11. PubMed ID: 16608048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration.
    Abbott CA; Vileikyte L; Williamson S; Carrington AL; Boulton AJ
    Diabetes Care; 1998 Jul; 21(7):1071-5. PubMed ID: 9653597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tapentadol-ER for the treatment of diabetic peripheral neuropathy.
    Games G; Hutchison A
    Consult Pharm; 2013 Oct; 28(10):672-5. PubMed ID: 24129223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of neuropathy and plasma nitric oxide in recurrent neuropathic and neuroischemic diabetic foot ulcers.
    Jude EB; Tentolouris N; Appleton I; Anderson S; Boulton AJ
    Wound Repair Regen; 2001; 9(5):353-9. PubMed ID: 11896978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control.
    Miranda-Massari JR; Gonzalez MJ; Jimenez FJ; Allende-Vigo MZ; Duconge J
    Curr Clin Pharmacol; 2011 Nov; 6(4):260-73. PubMed ID: 22082324
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.